lly tirzepatide uk economic study Weight Loss Drugs in the UK: Public Health Investment or Risk? Eli Lilly Q4 2025 Results:

Pregnancy and breastfeeding Qelbree may cause harm to a developing fetus and is not recommended for use by women who are pregnant or may become pregnant

These include: Heart Conditions: If you have a history of heart disease, hypertension, or cardiovascular issues, consult your doctor before starting any exercise

The information provided is not a substitute for professional medical advice, diagnosis, or treatment

Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have proven remarkably effective at helping patients lose weight